National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
  Comparative Medicine
  Cytokine Biology
  LAD
  LCID
  LCMI
  LHD
  LHBP
  LIG
  LI
  LIP
  LID
  LIR
  LICP
   Chlamydial Pathogenesis
   Host-Parasite Interactions
   Salmonella Host-Cell Interaction
   Coxiella Pathogenesis
   Tularemia Pathogenesis
   Immunity to Pulmonary Pathogens
  MVDB
  LMVR
  LMI
  LMM
  LPD
  LPVD
  LVD
  LZP
  PSIIM
  Research Technologies
  Vaccine Research Center
 Find Key Lab Scientists
 Training in NIAID Labs


Laboratory of Intracellular Parasites

Immunity to Pulmonary Pathogens Section

Catharine (Katy) Bosio, Ph.D.

Chief, Immunity to Pulmonary Pathogens Section

Description of Research Program

The focus of our research is to gain a better understanding of how aerosolized pathogens successfully infect and modulate the pulmonary environment to cause overt disease and death. Currently, our principal interest is the pathogenesis of aerosolized Francisella tularensis, the causative agent of pneumonic tularemia.

There are three primary areas of research ongoing in our laboratory: innate immunity to F. tularensis, vaccine development for pneumonic tularemia, and modulation of human cells by F. tularensis. We are particularly interested in modulation of primary antigen presenting cells (dendritic cells and macrophages) by F. tularensis and how this modulation allows the bacterium to initially evade host immune responses immediately following infection. We utilize both in vivo and in vitro models of disease to reveal specific mechanisms at play in both host and pathogen to gain a better understanding of the dynamic nature of this disease.

Research Group Members

Left to right: Katy Bosio, Debbie Crane, Norma Olivares Zavaleta, Jennifer Chase

 

 Immunity to Pulmonary Pathogens Section group members.

Selected Recent Publications

(View list in PubMed.)

K.L. Elkins, S. C Cowley and C. M. Bosio. Innate and adaptive immunity to Francisella. Ann NY Acad Sci. 2007 Jun. 1105: 284-324.

C. M. Bosio, H. Bielfeldt-Ohmann and J.T. Belisle. Active suppresion of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 2007 Apr 1; 178 (7): 4538-47.

X. Yang, B.J. Hinnebusch, T. Trunkle, C.M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, R. Avci and D. Pascual. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol. 2007 Jan 15;178(2):1059-67.

K. Zaks, M. Jordon, A. Guth, K. Sellins, R. Kedl, A. Izzo, C. Bosio and S. Dow. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol. 2006 Jun 15;176(12):7335-45.

C.M. Bosio, A.Goodyear, and S. Dow. Early interaction of Yersinia pestis with APCs in the lung. J. Immunol. 2006. 175(10): 6750-6.

C.M. Bosio and Dow S. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 2006. 175(10): 6792-801.

back to top

LICP Chief, Dr. Catharine Bosio

Contact Info

Catharine Bosio, Ph.D.
Phone: 406-363-9292
E-mail:
bosioc@niaid.nih.gov
Mail:
Rocky Mountain Laboratories
NIAID/NIH
903 South 4th St.
Hamilton, MT 59840


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

Search in Labs at NIAID
 
Print Icon Print this page
E-mail Icon E-mail this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.
LICP Chief, Dr. Catharine Bosio

Contact Info

Catharine Bosio, Ph.D.
Phone: 406-363-9292
E-mail:
bosioc@niaid.nih.gov
Mail:
Rocky Mountain Laboratories
NIAID/NIH
903 South 4th St.
Hamilton, MT 59840


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)